Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0024530 (malaria)
 44,886 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Sera of negroes of African origin and of indians, living in a malaria endemic village on the Pacific Coast of Colombia, were analyzed to see if they could block intraerythrocytic Plasmodium falciparum growth in vitro. A group of mestizos from a malaria-free city in Colombia was used as a negative control. Blood of each individual was studied for the presence of circulating parasites by thick and thin smears and their sera for antimalarial antibodies by IFAT and IRMA techniques. The inhibition of the intraerythrocytic growth induced by these sera was assessed by [3H]Hypoxanthine incorporation. All groups showed inhibitory activity independent of their exposure to malaria. Negro sera had the highest inhibitory activity even following the removal of antibody, and also the highest antimalarial antibody titers. The group of indians had reduced inhibitory activity and lower antibody titers compared to the negro sera. In the group of mestizos, who reported no malaria exposure, 14% had antibodies to asexual blood forms of P. falciparum and 60% induced significant inhibition.
 ...
PMID:Malaria crisis activity in sera from individuals of different ethnic groups of Colombia. 228 55

Specific monoclonal antibody (MAB) F2W22C1) produced by hybridoma technology against blood stage common antigens shared by almost all isolates of P. falciparum was selected. The 125I-labelled prepared from this MAB (125I-MIgG) was used as probe for detection of low grade P. falciparum infection. Recently, a two-site monoclonal antibody sandwich immunoradiometric assay (Mab-IRMA) has been developed. The assay showed good correlation with parasitaemia with the ability to detect as few as 2.4 parasites/10(8) erythrocytes. Two surveys were made in people living in a malaria endemic area during transmission and non-transmission season to detect the antigen of Plasmodium falciparum by using the Mab-IRMA. In the first survey involving 101 people, the IRMA positive rate was 56.4% and then significantly declined to 16.5% during the second survey involving 79 people of the same group. The parasitological positive rates were likewise decreased from 11.9% to 1.3% (p = 0.015) during these two seasons. IRMA positive rates were significantly higher than the corresponding parasitological positive rates (p less than 0.0001 and less than 0.002 for the first and the second surveys respectively). Regression analysis showed that IRMA activities were linearly correlated with the parasite counts by microscopic examinations (r = 0.629, p = 0.022). IRMA was specific for P. falciparum since all 30 healthy controls and six of seven vivax malaria cases were negative. IRMA has potential for use to monitor the malaria control and to assess the efficacy of the future field trial of malaria vaccine.
 ...
PMID:Development of immunoradiometric assay for detection of Plasmodium falciparum antigen in blood using monoclonal antibody. 304 98

Among vector-borne diseases malaria is the leading cause of morbidity in the world, with more than 200 million cases per year and a large number of deaths. The techniques traditionally used for the detection of Plasmodium in humans and Anopheles mosquitoes include microscopy, IRMA, ELISA, antibody or molecular assays, and anopheline dissection. However, these techniques are limited by their requirement of skilled personnel, low sensitivity or long processing times. A PCR-based high-resolution melting (PCR-HRM) analysis was developed for the detection and identification of P. falciparum, P. vivax and P. malariae that infect humans and Anopheles. In 41 human samples PCR-HRM detected 14 samples positive for P. vivax, 17 for P. falciparum, three for P. malariae, three mixed infections for P. vivax/P. malariae and four negative samples. Whereas benchmarking assays of microscopy and nested PCR had false positive detections. Additionally, PCR-HRM was able to detect natural infection with Plasmodium spp. in An. darlingi and An. mattogrossensis. The PCR-HRM presented is the first single assay developed for the detection and identification of P. vivax, P. falciparum and/or P. malariae in human and Anopheles. This method improves on currently available assays as it is easy-to-use, rapid, sensitive and specific with a low risk of contamination.
 ...
PMID:A new high-resolution melting analysis for the detection and identification of Plasmodium in human and Anopheles vectors of malaria. 3073 20